Original Research

Anlotinib as Exploratory Therapy for Platinum-Resistant Ovarian Cancer: A Retrospective Study on Efficacy and Safety

Ni J, Cheng X, Chen J, Guo W, Dai Z

OncoTargets and Therapy 2020, 13:9857-9863

Published Date: 5 October 2020